Lantheus Holdings Inc (NASDAQ:LNTH) insider Michael P. Duffy sold 6,908 shares of Lantheus stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $24.84, for a total value of $171,594.72. Following the completion of the transaction, the insider now owns 153,313 shares of the company’s stock, valued at $3,808,294.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
NASDAQ:LNTH traded down $1.45 during trading hours on Friday, hitting $24.25. 208,123 shares of the stock traded hands, compared to its average volume of 322,159. The company has a quick ratio of 3.82, a current ratio of 4.57 and a debt-to-equity ratio of 3.16. Lantheus Holdings Inc has a fifty-two week low of $12.59 and a fifty-two week high of $26.40. The company has a market cap of $941.39 million, a P/E ratio of 25.80, a price-to-earnings-growth ratio of 1.92 and a beta of 1.52.
Lantheus (NASDAQ:LNTH) last posted its quarterly earnings results on Tuesday, April 30th. The medical equipment provider reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03. Lantheus had a net margin of 12.17% and a return on equity of 59.57%. The business had revenue of $86.51 million for the quarter, compared to analysts’ expectations of $86.80 million. Equities research analysts anticipate that Lantheus Holdings Inc will post 1.11 earnings per share for the current year.
A number of equities research analysts have weighed in on the company. TheStreet upgraded Lantheus from a “c+” rating to a “b” rating in a research report on Monday, March 4th. Zacks Investment Research cut Lantheus from a “buy” rating to a “hold” rating in a report on Wednesday, February 6th. Finally, BidaskClub cut Lantheus from a “strong-buy” rating to a “buy” rating in a report on Thursday, April 18th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $23.33.
TRADEMARK VIOLATION NOTICE: “Michael P. Duffy Sells 6,908 Shares of Lantheus Holdings Inc (NASDAQ:LNTH) Stock” was posted by Tech Know Bits and is the sole property of of Tech Know Bits. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://techknowbits.com/2019/05/18/michael-p-duffy-sells-6908-shares-of-lantheus-holdings-inc-lnth-stock.html.
Lantheus Holdings, Inc develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, a microbubble contrast agent used in ultrasound exams of the heart; and TechneLite, a technetium generator that provides the nuclear material used in nuclear medicine procedures.
Read More: How does new data get added to a blockchain?
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.